Astria Therapeutics
ATXS
ATXS
58 hedge funds and large institutions have $85.6M invested in Astria Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
Holders
58
Holding in Top 10
–
Calls
$269K
Puts
$290K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$12.1M | |
| 3 | +$8.52M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.49M |
| 5 |
VA
VR Adviser
New York
|
+$6.82M |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$2.07M | |
| 3 | -$1.04M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$677K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$366K |